A Chinese Scientist Claims The Establishment of A Human Somatic Cell Nuclear Transfer Cloning Technology Platform

Online, August 11, 2014 (Newswire.com) - Recently, Li, Jianyuan, a Chinese scientist claims that his research team has established a human somatic cell nuclear transfer cloning technology platform and they has mastered the world's most sophisticated human embryo cloning techniques. According Li, his research center has successfully cloned five human embryos which are in consistent with internationally recognized human blastocysts technical evaluation indicators. Their research results have been published in CLONING AND STEM CELLS, a cloning and stem cell authoritative international academic journal, on January 27th.

Professor Li said that this advanced technology is not for human cloning, but for human therapeutic cloning research, and for the benefit of mankind. It is foreseeable that in the near future, a variety of incurable diseases are likely to be treated by utilizing the technology of cloning. The present cloning technology can extract versatile embryonic stem cells that are genetically identical to the patients' cloning embryos. The new cells, tissues or organs can replace the diseased cells, tissues, organs, and thus avoiding immune rejection.

That's really an exciting news. And we can say that the application of cloning technology will be even more widespread apart from disease treatment. Without doubts, cloning technology will play a much more important role in future researches.

However, not every laboratory has the ability and time to engage in cloning. The cloning technology is a cutting-edge technology which can't be mastered by everyone. To build a cloning platform is also time and money consuming. How can research institutions, organizations, and companies achieve their cloning purpose without adding any new equipment and staff?

Here goes the answer. Creative Biogene is a leading genomic service provider in the world and their comprehensive range of services are supported by leading technology platforms "REC"(rapid and efficient cloning). Creative Biogene has rich experience in cloning genomic DNA from many species with a variety of difficulties such as high GC content, hairpin structure, repetitive sequences.